This invention relates generally to solution separation and, in particular, to systems and methods for multiplexing and for separating native aggregates into narrower ensembles.
Whole blood is a suspension of particles (e.g., red blood cells and white blood cells) in a proteinaceous liquid (plasma). Whole blood is routinely examined for the presence of abnormal organisms or cells, such as fetal cells, nucleic acids, parasites, microorganisms, and inflammatory cells. Recently blood has been examined for the presence of cancer cells. Blood is typically analyzed by smearing a sample on a slide and is stained and visually studied usually by bright field microscopy, and then, when needed, by immunologic stains and/or other molecular techniques. Visual detection of cancer cells or foreign bodies in blood is dependent on the efficient labeling of targets with a fluorescent tag and the microscopic detection of that tag, or on morphological characteristics of cancer cells or foreign bodies.
Whole blood samples can also be collected to detect a variety of different viruses, for example, HIV, cytomegalovirus, hepatitis C virus, and Epstein-Barr virus. In some cases, practitioners, researchers, and those working with various samples use dyes and fluorescent proteins to detect these viruses. Unfortunately, these dyes and fluorescent proteins have a number of disadvantages which may render their observation inconclusive. The dyes and fluorescent proteins are not very bright, have wide emission spectra, and suffer from photobleaching.
This disclosure is directed to systems and methods for sorting a native aggregate, such as a fluorescent nanoparticle aggregate, which includes multiple objects, some of which have different characteristics, into lower level ensembles, such as monochromatic nanoparticle ensembles. In one aspect, the system includes two detectors, one of which accepts all emitted wavelengths and another one which is preceded by a filter to permit transmission of a specific wavelength or range of wavelengths. In another aspect, the system includes multiple detectors, each detector configured to detect a given wavelength or range of wavelengths, such that no two detectors have overlapping wavelengths or ranges. In yet another aspect, the system includes an optical regulator in front of a detector. This disclosure is also directed to systems and methods for multiplexing and analyzing a target analyte using the monochromatic nanoparticle ensembles.
In the following description, the term “light” is not intended to be limited to describing electromagnetic radiation in the visible portion of the electromagnetic spectrum, but is also intended to describe radiation in the ultraviolet and infrared portions of the electromagnetic spectrum.
For the sake of convenience, the methods and systems are described with reference to an example light source of quantum dots and quantum dot aggregates. But the methods and systems described below are not intended to be so limited in their scope of application. The methods and systems, in practice, can be used with any kind of light-emitting or fluorescent nanoparticle and are not intended to be limited to quantum dots and quantum dot aggregates. For example, light-emitting or fluorescent nanoparticles may include, but are not limited to, nanometer-sized detection probes, nanodiamonds, Cornell dots (fluorescent dye encapsulated in a silica shell), DNA barcodes, and the like.
It should be further noted that the emission width, range, spectrum, or deviation of the fluorescent nanoparticles is represented by full width at half max (“FWHM”). The emission width, range, spectrum, or deviation may occur at any appropriate temperature, including, but not limited to, at or below freezing, between freezing and room temperature, at approximately room temperature, above room temperature, or the like.
Quantum dots are small nanometer sized particles with multiple unique properties. The quantum dots are made from periodic groups II-VI, III-V, or IV-VI materials including, but not limited to cadmium selenide, cadmium sulfide, zinc sulfide, zinc telluride, indium arsenide, and indium phosphide. Quantum dots, as referenced herein, shall also include luminescent silicon and carbon-based nanoparticles.
The primary advantages of quantum dots include: archival capability, since there is little or no noticeable bleaching or fading after years; quantitative fluorescence, providing a characteristic, repeatable emission for a given amount of incident photon flux; extremely high photo efficiencies, approaching 90%; emission lifetimes that can be orders of magnitude longer than organic fluorophores; ability to absorb high photon flux; external surface capable of conjugating to molecular markers, such as antibodies; narrow emission spectra for individual quantum dots; and small sizes of 1-100 nm.
Quantum dots are important markers for research, discovery and diagnostic applications. Archival stability is desirable for slide specimens, such as biopsies for pathological examination, which may need multiple examinations and re-examination over times ranging from days to years. Minimal photobleaching, if any, permits the sample to be stored for an extended amount of time for multiple examinations as needed or required. The various attributes of quantum dots, such as bright emissions, also make it possible for in-vivo imaging of model organisms such as mice. Quantum dots may also be used to provide controlled light sources for scientific applications. It should be further noted that as the number of quantum dots in a sample increases, the brightness of the light emission increases. The brightness of the light emission is therefore proportional to the number of quantum dots present.
A quantum dot aggregate is typically created with various sizes of quantum dots within one manufacturing sample. Quantum dots are typically manufactured by “growing” a core substrate in solution or by performing laser ablation or electric arc discharge of certain materials. The distribution of quantum dot sizes and the resulting emission spectra (since the emission spectrum can be dependent on the size of the quantum dot) fall into a standard bell curve. The fluorescent property of the quantum dot may be based on the size, on the number of layers or coatings, or an attached particle, depending on the base from which the quantum dot is derived or other attributes. The quantum emission of light is very important. An individual quantum dot can emit monochromatic light, with an emission width only a few nanometers in width, even as narrow as 1 nm (at approximately 5 Kelvin). Small changes in physical properties of quantum dots, such as size, may shift the emission wavelength slightly, thereby providing individual quantum dots with different emission colors.
The broad emission spectrum of a quantum dot aggregate reduces the functionality of quantum dots for some applications. For example, in imaging applications for research and diagnostics it is desirable to simultaneously detect and observe as many objects as practical. The broad emission of ensemble quantum dots causes difficulties in separating the overlapping spectra from one quantum dot aggregate from the spectra of an adjacent quantum dot aggregate. For example, even with a combination of interference filters that have exceptionally narrow band passes, differentiating between quantum dots in a 525 nm ensemble from those in a 545 nm ensemble would be difficult due to the overlap in each ensemble's broad emission curve. Complex methods have been developed, usually involving spectral unmixing in an attempt to resolve this problem but these methods are time consuming, and may even provide an incorrect result. As assays become more sensitive and attempt to identify lower concentrations of analyte, fewer quantum dots will be present in the sample. The underlying ensemble distribution may no longer accurately represent this sparse quantum dot distribution. Indeed, as the number of quantum dots is reduced it may be difficult to determine whether the emission at 545 nm is from the ensemble of 525 nm, 545 nm, or 565 nm.
A “monochromatic dot ensemble” (“MDot ensemble”) is an ensemble with a spectral range that is less than the spectral range of a native aggregate. The native aggregate may be a quantum dot aggregate or any higher level aggregate which includes multiple objects, some of which have different characteristics, such that it may be desirous to sort, develop, or separate those objects based on their differing characteristics. The MDot ensemble spectral range may be from 100 nanometers down to 1 or 2 nanometers. Sorting quantum dot aggregates into MDot ensembles is accomplished by analyzing the emission wavelength of each quantum dot, and then directing the quantum dot into an appropriate MDot ensemble, such that each quantum dot within a given MDot ensemble has an emission wavelength which deviates from a specified wavelength by a pre-determined amount. The pre-determined deviation may be 0 to 500 nm from the specified wavelength (i.e. ±0-500 nm from specified wavelength), including deviations of 50 nm, 10 nm, 5 nm, 1 nm. The monochromatic dot ensemble may have an emission spectra that is less than or equal to one-half of the emission spectra of the native aggregate from which the monochromatic dots were sorted, separated, or developed. The monochromatic dot ensemble may have an emission spectra that is less than or equal to one-third, one-quarter, one-tenth, one-hundredth or the like of the emission spectra of the native aggregate from which the monochromatic dots were sorted, separated, or developed. Sorting by emission wavelength maintains a consistently narrow spectrum within the MDot ensemble, whereas size sorting does not.
The systems disclosed are capable of separating a native aggregate into narrower ensembles and detecting a multiplexed analyte. When sorting, the systems separate a quantum dot aggregate into MDot ensembles. When detecting, the systems analyze an analyte for the presence of quantum dots from multiple MDot ensembles.
For the sake of convenience, the methods and systems are described with reference to a system using hydrodynamic focusing, such as a fluorescence activated cell sorter (“FACS”), or using an imaging device, such as a fluorescent microscope. But the methods and systems described below are not intended to be so limited in their scope of application. For example, a quantum dot aggregate may be sorted based on the mass or the size of the quantum dots, such as by performing ultracentrifugation, gel electrophoresis, or high pressure liquid chromatography. The methods and systems, in practice, can be used with any kind of analysis or imaging device, such as a microfluidic chip. For example, a sample may by analyzed using digital microfluidics. In digital microfluidics, the sample is introduced onto a chip and is able to be controlled to perform a multitude of functions with the use of electrodes. An analyte may be analyzed for emission light or lights and a quantum dot aggregate may be separated into MDot ensembles. Furthermore, when using hydrodynamic focusing or any fluidics, the flow rate of the sample may be reduced so as to increase exposure time to both a light source and a detector. Furthermore, the system, such as the FAGS or microfluidic chip, may include a mirrored surface or many mirrored surfaces to reflect the emission light to a detector, thereby increasing the amount of emission light that is captured by the detector. Furthermore, a light source and a detector may be elongated, so as to excite and detect over a greater distance, thereby allowing for increased detection time.
Identifying multiple emissions of MDots may be accomplished by several methods, such as interference filters or spectral-based systems such as an acousto-optical tunable filter (“AOTF”), filter wheel, digital microfluidics, or tunable LCD system. For example, a MDot ensemble is provided with a distribution less than or equal to 5 nm. In this instance, 5 nm bandpass filters on 10 nm centers may be used to detect up to 41 biological markers in the visible (375-775 nm) spectrum, though any emission is contemplated within the spectrum ranging from about 390 nm to about 1000 nm or greater, limited only by the emission characteristics of the quantum dot aggregate. Using narrower filters could increase the density to over 100 markers in a single sample. Using 1 nm bandpass filters may permit the operator to select even more biological markers from a given sample.
A first filter 322 may be placed in front of a first detector 324. The first filter 322 may be a narrow bandpass filter, thereby permitting an emission that occurs within the narrow band to pass through to the first detector 324, such that the first detector 324 detects a first, narrow emission. A second detector 326 detects all emissions. A second filter (not shown) may be placed in front of the second detector 326 to permit passage of all emissions while blocking the passage of the light produced by the light source. The emissions detected by the first and second detectors 324 and 326 are compared. When the emissions are the same, the droplet, such as droplet 310, may be diverted into a first vessel 316; when the emissions are different, such as in droplet 308, or no emissions are detected, such as in droplet 309, by the first detector 322, the droplet, may be diverted into a second vessel 318. The accumulation then present in the second vessel 318 may then be re-processed for further separation. Alternatively, when there are no emissions detected by the first detector 322, the droplet, such as droplet 309, may be diverted into a third vessel (not shown), while the droplet 308 may be diverted to the second vessel 318.
Alternatively, the analyzer 300 may also include more than 2 vessels into which the quantum dots are separated. Each vessel may have a different frequency range and the quantum dots can be diverted into the respective vessels. A quantum dot aggregate can therefore be broken up into multiple MDot ensembles without having to re-process and re-separate each vessel.
Alternatively, the first and second detectors 324 and 326 and the first filter 322 may be integrated into a fluorescent microscope, including a scanning fluorescent microscope. The fluid 306 may be analyzed on a microscope slide or in a vessel, such as a tube.
The filter may be a bandpass filter, an interference filter, a dichroic filter, or a tunable filter, such as an AOTF. The tunable filter allows for selection and transmission of a single wavelength of light. Any size bandpass filters are contemplated, including 1 nm, 5 nm, and 10 nm bandpass filters. The bandpass filters may also be used during multiplexed imaging and detection. When multiple bandpass filters are used, the bandpass filters may be arranged within a filter wheel or among different detectors.
Another method for separation of a quantum dot aggregate involves the use of successive detectors and deflectors. By separating the quantum dot aggregate at successive levels, the accumulations at each respective level may be separated further and further into narrower and narrower accumulations the initial quantum dot aggregate is separated into appropriate MDot ensembles. The first level will be “coarser” in nature, thereby having first-level containers with wider emission frequency ranges. The subsequent levels will be “finer” in nature, thereby having successive containers with narrower emission frequency ranges. The process occurs in successive levels until the quantum dot aggregate is broken up into containers having appropriate MDot ensembles. The MDot ensembles may include emission ranges from 0 nm to 100 nm, wherein the emission range is the difference between the wavelength of an emission light of the longest wavelength emitted by a quantum dot in the MDot ensemble and the wavelength of an emission light of the shortest wavelength emitted by another quantum dot in the MDot ensemble.
Each one of the detectors 334-341 is configured to detect a single emission wavelength from a fluid at a given point, such that none of the detector ranges overlap with another detector range. The fluid is broken up into droplets, such as droplet 308, at the end of the nozzle 302, each droplet is charged, and the droplet is then diverted to a vessel via charged deflection plates 312 and 314 based on the detected emission, detected emissions, or absence of any emission. To sort, for example, a droplet including a single emission wavelength may be diverted into a first container, whereas another droplet including multiple emission wavelengths may be diverted into a second container (and subsequently re-processed to further sort). For example, an analyte may be conjugated with quantum dots from different MDot ensembles. A first detector detects a first wavelength emission; a second detector detects a second wavelength emission; and so on. Based on the detected wavelengths, the analyte is included in a droplet, the droplet is charged, and the droplet is then diverted to a vessel via charged deflection plates based on the detected emission or emissions. An analyte emitting 5 wavelengths may be diverted into a vessel for collecting circulating tumor cells, whereas an analyte emitting 3 wavelengths may be diverted into a vessel for collecting white blood cells.
Alternatively, a series of filters, such as bandpass filters may be used to reduce the number of detectors. A first line of filters include keying filters, such that each keying filter is linked to a series of subsequent filters, such as dichroic filters, based on the wavelength of the signal. For example, keying filter #1 is linked to Filter A1, Filter B1, Filter C1, and Filter D1. When the signal has a wavelength appropriate for keying filter #1, the signal is also processed by Filters A1-D1. Keying filter #2 is linked to Filter A2, Filter B2, Filter C2, and Filter D2, and so on.
An analyzer may include an optical regulator, such a photomask, a prism, a grating, a grating prism, or the like, to manipulate emission lights prior to being detected by a detector.
Alternatively, a tunable filter or a filter wheel including multiple bandpass filters may be used. Multiple images may be taken, whereby each image only contains a singular wavelength, and each image is then analyzed individually. For example, a first bandpass filter on the filter wheel may allow light having a wavelength between 475 nm and 485 nm to pass. The 480 nm wavelength will pass and an image will be taken. The bandpass filter, being either tunable or having a multiple filters, each filter having a distinct range, may then permit the passage of light having a wavelength of 550 nm to 560 nm. An image may then be taken. Each image, having distinct wavelengths displayed, may be analyzed. A secondary filter (not shown) may also be used to permit the passage of emission light or lights, while inhibiting the passage of scatter from the light source 320.
Alternatively, a grating prism may be used. The grating prism is a combination of a prism and a grating, such that a chosen wavelength is permitted to pass straight through. The grating prism may act like a filter by passing a chosen wavelength. However, the grating prism does not reject other wavelengths, if present. By diffracting and/or refracting the non-desired wavelengths, the grating prism may allow for subsequent processing of the non-desired wavelengths.
Alternatively, each fiber optic cable receives emission lights having different wavelengths. The fiber optic cables may be preceded by a prism, a grating, or the like, to disperse the signal into signal components across the fiber optic cables. Each fiber optic cable may receive a different component and transmit the component accordingly. Alternatively, each fiber optic cable may be preceded by a respective filter, such that each filter permits passage, and subsequent detection, of a specific wavelength, and whereby no two filters permit passage of overlapping or equal wavelengths. The fiber optic cables then transmit the emission lights to the detector 374 or many detectors. When many detectors are used, each fiber optic cable transmits the emission light to a respective detector. The fiber optic cables may be formed in any appropriate configuration, such a ring, in a line, in a stack, staggered, or the like, such that each fiber optic cable is capable of receiving emission light.
Alternatively, a tunable filter or a filter wheel including multiple bandpass filters may be used. Multiple images may be taken, whereby each image only contains a singular wavelength, and each image is then analyzed individually. For example, a first bandpass filter on the filter wheel may allow light having a wavelength between 475 nm and 485 nm to pass. The 480 nm wavelength will pass and an image will be taken. The bandpass filter, being either tunable or having a multiple filters, each filter having a distinct range, may then permit the passage of light having a wavelength of 550 nm to 560 nm. An image may then be taken. Each image, having distinct wavelengths displayed, may be analyzed. A secondary filter (not shown) may also be used to permit the passage of emission light or lights, while inhibiting the passage of scatter from the light source 414.
Each one of the detectors 431-437 is configured to detect a single emission wavelength, such that none of the detector ranges overlap with another detector range. For example, an analyte may be conjugated with quantum dots from different MDot ensembles. A first detector detects a first wavelength emission; a second detector detects a second wavelength emission; and so on.
Alternatively, the grating prism may be used. The grating prism is a combination of a prism and a grating, such that a chosen wavelength is permitted to pass straight through. The grating prism may act like a filter by passing a chosen wavelength. However, the grating prism does not reject other wavelengths, if present. By diffracting and/or refracting the non-desired wavelengths, the grating prism may allow for subsequent processing of the non-desired wavelengths.
An imager, similar to one shown in
It should be noted that the emission light 420, though represented by a single dashed line, may actually be composed multiple wavelengths. The emission light 420 was shown as the single dashed line to show the path taken by the emission light 420. The imager may be a fluorescent microscope, such as a stationary microscope and a scanning microscope.
The detector may include, but is not limited to, a charge coupled device (“CCD”), an active-pixel sensor, a CMOS sensor, a photodiode, and a photomultiplier tube. The signals captured by the detector or detectors may be integrated or compiled.
After a quantum dot aggregate has been sorted into MDot ensembles, the MDot ensembles may be used in variety of applications, including, but not limited to, multiplexing a target analyte, tagging DNA origami, or within an illuminator.
It may be desirous to use as many markers as possible to identify various characteristics of a target analyte. The target analyte may have a number of different types of surface markers. Each type of surface marker is a molecule, such an antigen, capable of attaching a particular ligand, such as an antibody. As a result, ligands can be used to classify the target analyte and determine the specific type of target analytes present in the sample by conjugating ligands that attach to particular surface markers with a particular quantum dot. For example, each type of quantum dot emits light in a narrow wavelength range of the electromagnetic spectrum called a “channel” when an appropriate stimulus, such as light with a shorter wavelength, is applied. A first type of quantum dot that emits light at a first wavelength can be attached to a first ligand that binds specifically to a first type of protein, while a second type of quantum dot that emits light at second wavelength can be attached to a second ligand that binds specifically to a second type of protein, and so on. The spectral purity of quantum dots permits 5 or more colors or emission ranges to be used, thereby permitting multiple ligands to be used and for multiple cellular occurrences and variations to be detected in the same sample. The channel color observed as a result of stimulating the target analyte identifies the type of protein, and because proteins can be unique to particular target analyte, the channel color can also be used to identify the target analyte.
Quantum dots also enable new applications such as improved illumination systems for microscopy, deterministic detection of rare or low level events, and significant increases in the number of reporting markers. Quantum dots may also be used to tag components of DNA, such as nucleotides, within DNA origami. This allows for the use of multiple quantum dots for fluorescent in-situ hybridization (“FISH”). Currently, implementation of quantum dot aggregates within DNA origami is limited due to the spectral overlap of the quantum dot aggregates.
Alternatively, nucleic acid components, such as nucleotides or nucleotide sequences, or nucleic anomalies, such as single nucleotide polymorphisms, may be detected with a quantum dot from different MDot ensembles, thereby associating a specific wavelength or wavelength range with a specific nucleotide or nucleotide sequence. Specifically detecting each nucleic acid strand component allows for enumeration and detection of the various nucleic acid strand components. The nucleic acid strand may include a DNA strand, a RNA strand, or the like.
It should be understood that the method and system described and discussed herein may be used with any appropriate suspension or biological sample, such as blood, bone marrow, cystic fluid, ascites fluid, stool, semen, cerebrospinal fluid, nipple aspirate fluid, saliva, amniotic fluid, vaginal secretions, mucus membrane secretions, aqueous humor, vitreous humor, vomit, and any other physiological fluid or semi-solid. It should also be understood that a target analyte can be a cell, such as ova or a circulating tumor cell (“CTC”), a circulating endothelial cell, a vesicle, a liposome, a protein, a nucleic acid, a biological molecule, a naturally occurring or artificially prepared microscopic unit having an enclosed membrane, parasites, microorganisms, or inflammatory cells.
The foregoing description, for purposes of explanation, used specific nomenclature to provide a thorough understanding of the invention. However, it will be apparent to one skilled in the art that the specific details are not required in order to practice the invention. The foregoing descriptions of specific embodiments of the present invention are presented for purpose of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms disclosed. Many modifications and variations are possible in view of the above teachings. The embodiments are shown and described in order to best explain the principles of the invention and its practical applications, to thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the following claims and their equivalents:
This application claims the benefit of Provisional Application No. 61/771,697, filed Mar. 1, 2013.
Number | Date | Country | |
---|---|---|---|
61771697 | Mar 2013 | US |